Global Campaign for Microbicides


Home » About Microbicides » Testing & Trials » Trial Results » MDP 301: PRO 2000

MDP 301: PRO 2000

Announcing the MDP 301 PRO 2000 Trial Results

The Microbicides Development Programme (MDP) announced the highly anticipated results of MDP 301 study testing the safety and effectiveness of 0.5% PRO 2000 on Monday, 14 December 2009.  The clinical trial involving 9385 women in East and Southern Africa has demonstrated that a vaginal microbicide gel PRO 2000 (0.5%) while safe does not prevent HIV infection in women.

Resources about the MDP 301 Trial and Results

Advocates call

Press Releases

Anticipating the Results - Resources available prior to results.